Abstract:Ghrelin is an endogenous ligand of growth hormone (GH) secretagogue receptor (GHSR) and has a number of biological effects, including heart protection. The present study aimed to reveal the positive effect of ghrelin on myocardium with hypoxia/reoxygenation (H/R) treatment and the involved molecular mechanisms. Successful construction of lentiviral expression vector (ghrelin-pLVX-Puro) was confirmed by colony polymerase chain reaction (PCR) verification. Primary rat cardiac myocytes were isolated and identified by immunofluorescence staining. Existence of red fluorescence of alpha-sarcomeric actinin indicated the successful isolation. Following ghrelin transfection and H/R treatment, primary cells were divided into four groups: Control, H/R, empty (empty pLVX-Puro + H/R) and ghrelin (ghrelin-pLVX-Puro + H/R). Cell viability and apoptosis were evaluated by Cell Counting Kit-8 (CCK-8) and Hoechst staining, respectively. The cell viability in the ghrelin group was significantly higher than that in the empty control group (P<0.05). The apoptosis rate in the ghrelin group was significantly lower than that in the empty control group (P<0.05). An ex vivo rat cardiac perfusion model was established. Following ghrelin incubation and H/R treatment, ex vivo myocardium was divided into four groups: Control, sham, H/R and ghrelin (ghrelin + H/R). Immunohistochemical analysis demonstrated that ghrelin increased the integrity of cardiac myocytes, and decreased shrinkage and apoptosis. mRNA and protein expression levels of GH, GHSR, insulin-like growth factor-1 (IGF-1), protein kinase B (Akt), phosphorylated Akt (p-Akt) were determined by reverse transcription (RT)-PCR, western blot analysis and immunohistochemical analysis. Ghrelin upregulated the mRNA and protein expression levels of GH, GHSR and IGF-1, and increased the ratio of p-Akt to Akt protein level (p-Akt/Akt) in cardiac myocytes and myocardial tissues with H/R treatment. In conclusion, ghrelin protected the myocardium with H/R treatment through upregulating the expression of GH, GHSR and IGF-1, and promoting the phosphorylation of Akt. This would provide promising insights into the treatment of hypoxic myocardial injury by ghrelin.

Ghrelin Protects H9c2 Cardiomyocytes from Angiotensin Ii-Induced Apoptosis Through the Endoplasmic Reticulum Stress Pathway

Ghrelin Protects H9c2 Cells from Hydrogen Peroxide-Induced Apoptosis Through NF-κB and Mitochondria-Mediated Signaling

Mechanisms of Ghrelin Anti-Heart Failure: Inhibition of Ang II-induced Cardiomyocyte Apoptosis by Down-Regulating AT1R Expression.

Ghrelin Protects Heart Against ERS-induced Injury and Apoptosis by Activating AMP-activated Protein Kinase

Inhibition of Endoplasm Reticulum Stress by Ghrelin Protects Against Ischemia/reperfusion Injury in Rat Heart.

Hexarelin Protects Rat Cardiomyocytes from Angiotensin II-induced Apoptosis in Vitro

Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways.

Ghrelin Protects the Myocardium with Hypoxia/reoxygenation Treatment Through Upregulating the Expression of Growth Hormone, Growth Hormone Secretagogue Receptor and Insulin-Like Growth Factor-1, and Promoting the Phosphorylation of Protein Kinase B

Ghrelin inhibited pressure overload-induced cardiac hypertrophy by promoting autophagy via CaMKK/AMPK signaling pathway

Ghrelin ameliorates cardiac fibrosis after myocardial infarction by regulating the Nrf2/NADPH/ROS pathway

Ghrelin Suppresses Cardiac Fibrosis of Post-Myocardial Infarction Heart Failure Rats by Adjusting the Activin A-follistatin Imbalance

Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanisms

Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms

Detrimental effect of Ghrelin on hypoxia/reoxygenation- induced injury of H9c2 cells by enhancing cell autophagy

Ghrelin Protects Human Umbilical Vein Endothelial Cells Against High Glucose-Induced Apoptosis Via Mtor/p70s6k Signaling Pathway

Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway

Ghrelin Inhibits Doxorubicin Cardiotoxicity by Inhibiting Excessive Autophagy Through AMPK and P38-Mapk.

Ghrelin mediated cardioprotection using in vitro models of oxidative stress

Ghrelin protects against cobalt chloride-induced hypoxic injury in cardiac H9c2 cells by inhibiting oxidative stress and inducing autophagy

Ghrelin Inhibit Cell Apoptosis in Pancreatic Β Cell Line HIT-T15 Via Mitogen-Activated Protein Kinase/phosphoinositide 3-Kinase Pathways

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway